About BGI Australia

Founded in Brisbane, Queensland, Australia

Due to BGI's growing presence and influence in the world, BGI Australia was established in August 2016 to support its growth in the Asia-Pacific region. Its office is located at the prestigious QIMR Berghofer Medical Research Institute in Herston, Brisbane, Queensland. BGI Australia will continuously pursue collaborative opportunities throughout Queensland and Australia to pursue scientific excellence.

BGI Australia Laboratory

BGI Australia Laboratory, which is BGI’s first southern hemisphere genomics laboratory, is launched in May 2017, unveiling of its cutting-edge sequencer's debut in this part of the world. Being a subsidiary of the world's largest genomic organisation with leading  gene sequencing platform and superb genome sequencing and bioinformatics analysis capability, BGI Australia is devoted to facilitating cutting-edge research in the areas of healthcare, agriculture and environment. 

Local Research Collaborations

BGI Australia has established collaborations with leading research institutions such as QIMR Berghofer Medical Research Institute, CSIRO, the University of Queensland, Griffith University and James Cook University to carry out scientific research and innovative projects in relation to human medicine, health science, sports science, marine science, biodiversity, agriculture and aquaculture. BGI Australia has been undergoing strategic discussions with universities and various organisations regarding future opportunities and partnerships.

About BGI Group

Trans-omics for a Better Life

  • BGI was founded in 1999 with the vision of using genomics to benefit mankind and has since become the largest genomic organization in the world. With a focus on research and applications in the healthcare, agriculture, conservation, and environmental fields, BGI has a proven track record of innovative, high profile research, which has generated over 2,000 publications, many in top tier journals such as Nature and Science. The organization also contributes to scientific communication by publishing the international research journal GigaScience. BGI’s distinguished achievements have made a significant contribution to the development of genomics throughout the world.  BGI’s goal is to make state of-the-art genomics highly accessible to the global research community and clinical markets by integrating the industry’s broadest array of leading technologies, including BGI's own BGISEQ sequencing platform, economies of scale, and expert bioinformatics resources. BGI also offers a wide portfolio of transformative genetic testing products across major diseases, enabling medical providers and patients worldwide to realize the promise of genomics-based diagnostics and personalized healthcare. BGI’s services and solutions are available in more than 60 countries around the world. Please visit the BGI Group website www.genomics.cn for more information. 

BGI Group & Organisations

BGI Research

BGI Research

BGI Research is dedicated to using the world class genomics platform to contribute to the public health. Relying on innovative integration of platforms to achieve major scientific breakthroughs in the basic research area and lead technology development, BGI Research has four major areas of focus: Personal genomics, Cancer, Reproductive health, and Molecular breeding. 

BGI College

BGI College

BGI College focus on innovative education and training for multidisciplinary talents in bioscience and bioindustry. Programs include joint education, external training (bioinformatics training, medical related training & genetic counselor training) and public education (popular science education & summer internship). More than 100 PhD students and 300 MSc students have been trained. 

China National Genebank

China National Genebank

China National Genebank is a platform integrating a large-scale bio-repository and an omics database, operated by BGI. Genebank's mission is to collect, preserve and utilize genomics resources, and to build a network fostering global communication and collaboration on biodiversity conservation and genetic resources utilisation. We have collected over 11.3 million samples (including human, animal, plant and microbe).

GigaScience

GigaScience

GigaScience is an open-access open-data journal for the publication of all types of biological studies that use or create large-scale data sets. With the goal of revolutionizing data accessibility, dissemination, organization, and use, GigaScience has a unique format that integrates article publication with the data-hosting and cloud-computing resources. In three years GigaDB has stored over 194 datasets and 36TB data.

BGI Agriculture

BGI Agriculture

BGI Agriculture Group, has an extensive scope including animal & plant new variety development, plantation, livestock breeding, agricultural product processing as well as circular ecological research and application with the aim to establish sustainable agricultural industry and guard national food security. It has a major focus on millet breeding, improvement and industry.

BGI Genomics

BGI Genomics

BGI Genomics provides a wide range of commercial next generation sequencing services and a broad portfolio of genetic tests for medical institutions, research institutions and other public and private partners. BGI Genomics’ mission is to leverage its genomics expertise in order to advance life science research and to improve human health by providing high quality, affordable genomics powered health solutions for everybody. 

BGI Forensics

BGI Forensics

BGI Forensics supplies the scientific, accurate and affordable DNA genotyping services, and standardizes the procedures for applying relevant technologies in the fields of human DNA identification, plant and animal identification and forensics science. Based on advanced BGI sequencing platform and database, BGI Forensics provides traditional foresic services, and also focuses on the research and development of new technologies in forensic genomics, forensic pathology, and forensics.

MGI

MGI

MGI is the manufacturer of BGI sequencers, focused on the development, production and distribution of in vitro diagnostic reagents, medical devices, research reagents and equipments. BGI became the first organization with the CFDA registration of next generation sequencing diagnostic products and medical devices. BGI acquired Complete Genomics, a Mountain View based sequencing technology company in 2013. In 2015, based on CG’s technology, MGI launched a new desktop high-throughput next-gen sequencer BGISEQ-500 and 50 in 2016, and MGISEQ-2000 and 200 in 2017.